Related Experiment Video
Updated: Aug 4, 2026

08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Differences between smokers and never-smokers in sensitivity to nicotine: a preliminary report
O F Pomerleau1, M Hariharan, C S Pomerleau
1Department of Psychiatry, University of Michigan School of Medicine, Ann Arbor 48108.
Addiction (Abingdon, England)
|January 1, 1993
Summary
Smokers develop tolerance to nicotine, showing lower plasma nicotine accumulation than non-smokers. Nicotine sensitivity in smokers inversely correlates with their usual nicotine intake, suggesting adaptation to regular exposure.
Area of Science:
- Pharmacology
- Neuroscience
- Physiology
Background:
- Nicotine exposure leads to physiological and pharmacokinetic adaptations.
- Understanding nicotine sensitivity differences between smokers and non-smokers is crucial for addiction research.
Purpose of the Study:
- To investigate nicotine sensitivity in smokers versus never-smokers.
- To explore the relationship between nicotine exposure history and physiological reactivity.
Main Methods:
- Administered intra-nasal nicotine aerosol doses to smokers and never-smokers.
- Measured plasma nicotine levels and physiological responses (heart rate, blood pressure).
- Calculated functional nicotine sensitivity by normalizing reactivity to plasma nicotine increments.
Main Results:
- Never-smokers exhibited significantly higher plasma nicotine accumulation per dose than smokers.
- Functional nicotine sensitivity in smokers was inversely related to their daily nicotine consumption.
- Never-smokers showed similar nicotine sensitivity to light smokers, despite no prior exposure.
Conclusions:
- Smokers develop pharmacokinetic tolerance to nicotine, reducing plasma nicotine levels.
- Nicotine sensitivity is modulated by chronic exposure, with higher intake leading to lower sensitivity.
- Adaptation to nicotine exposure influences physiological responses, diminishing sensitivity over time.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

